| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |


From the Department of Molecular Ophthalmology,*
Lions
Eye Institute, Perth; and the Centre for Ophthalmology and Vision
Science,
University of Western Australia,
Perth, Australia
Vascular endothelial growth factor (VEGF) has been strongly implicated in the development of choroidal neovascularization found in age-related macular degeneration. Normally expressed in low levels, this study investigates whether the overexpression of VEGF in the retinal pigment epithelium is sufficient to cause choroidal neovascularization in the rat retina. A recombinant adenovirus vector expressing the rat VEGF164 cDNA (AdCMV.VEGF) was constructed and injected into the subretinal space. The development of neovascularization was followed by fluorescein angiography, which indicates microvascular hyperpermeability of existing and/or newly forming blood vessels, and histology. VEGF mRNA was found to be overexpressed by retinal pigment epithelial cells and resulted in leaky blood vessels at 10 days postinjection, which was maintained for up to 31 days postinjection. By 80 days postinjection, new blood vessels had originated from the choriocapillaris, grown through the Bruchs membrane to the subretinal space, and disrupted the retinal pigment epithelium. This ultimately led to the formation of choroidal neovascular membranes and the death of overlying photoreceptor cells. By controlling the amount of virus delivered to the subretinal space, we were able to influence the severity and extent of the resulting choroidal neovascularization. These results show that even temporary overexpression of VEGF in retinal pigment epithelial cells is sufficient to induce choroidal neovascularization in the rat eye.
This article has been cited by other articles:
![]() |
O. Tatar, K. Shinoda, E. Kaiserling, G. Pertile, C. Eckardt, A. Mohr, E. Yoeruek, P. Szurman, K. U. Bartz-Schmidt, and S. Grisanti Early Effects of Triamcinolone on Vascular Endothelial Growth Factor and Endostatin in Human Choroidal Neovascularization Arch Ophthalmol, February 1, 2008; 126(2): 193 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Marneros, H. She, H. Zambarakji, H. Hashizume, E. J. Connolly, I. Kim, E. S. Gragoudas, J. W. Miller, and B. R. Olsen Endogenous endostatin inhibits choroidal neovascularization FASEB J, December 1, 2007; 21(14): 3809 - 3818. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, Y. Hu, K. Lu, J. G. Flannery, and J.-x. Ma Very Low Density Lipoprotein Receptor, a Negative Regulator of the wnt Signaling Pathway and Choroidal Neovascularization J. Biol. Chem., November 23, 2007; 282(47): 34420 - 34428. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Tatar, A. Adam, K. Shinoda, T. Eckert, G. B Scharioth, M. Klein, E. Yoeruek, K. U. Bartz-Schmidt, and S. Grisanti Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy Br. J. Ophthalmol., September 1, 2007; 91(9): 1183 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
A view on new drugs for macular degeneration DTB, July 1, 2007; 45(7): 49 - 52. [Full Text] [PDF] |
||||
![]() |
M. L. Springer, A. Banfi, J. Ye, G. von Degenfeld, P. E. Kraft, S. A. Saini, N. K. Kapasi, and H. M. Blau Localization of vascular response to VEGF is not dependent on heparin binding FASEB J, July 1, 2007; 21(9): 2074 - 2085. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ma, S. E. Lee, J. Guo, W. Qu, B. I. Hudson, A. M. Schmidt, and G. R. Barile RAGE Ligand Upregulation of VEGF Secretion in ARPE-19 Cells Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1355 - 1361. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Tatar, K. Shinoda, A. Adam, T. Eckert, C. Eckardt, K. Lucke, C. Deuter, K. U. Bartz-Schmidt, and S. Grisanti Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes Br. J. Ophthalmol., February 1, 2007; 91(2): 166 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T.V.M. de Jong Age-Related Macular Degeneration N. Engl. J. Med., October 5, 2006; 355(14): 1474 - 1485. [Full Text] [PDF] |
||||
![]() |
E. W.M NG and A. P ADAMIS Anti-VEGF Aptamer (Pegaptanib) Therapy for Ocular Vascular Diseases Ann. N.Y. Acad. Sci., October 1, 2006; 1082(1): 151 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Costa, R. Jorge, D. Calucci, J. A. Cardillo, L. A. S. Melo Jr, and I. U. Scott Intravitreal Bevacizumab for Choroidal Neovascularization Caused by AMD (IBeNA Study): Results of a Phase 1 Dose-Escalation Study. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4569 - 4578. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Cashman, L. Bowman, J. Christofferson, and R. Kumar-Singh Inhibition of Choroidal Neovascularization by Adenovirus-Mediated Delivery of Short Hairpin RNAs Targeting VEGF as a Potential Therapy for AMD. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3496 - 3504. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Slomiany and S. A. Rosenzweig Hypoxia-Inducible Factor-1-Dependent and -Independent Regulation of Insulin-Like Growth Factor-1-Stimulated Vascular Endothelial Growth Factor Secretion J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 666 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Neu, A. Afzal, H. Pan, E. Gallego, N. Li, S. L. Calzi, S. Caballero, P. E. Spoerri, L. C. Shaw, and M. B. Grant The dipeptide arg-gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 3151 - 3155. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Tatar, E. Kaiserling, A. Adam, F. Gelisken, K. Shinoda, M. Volker, B. A. Lafaut, K. U. Bartz-Schmidt, and S. Grisanti Consequences of verteporfin photodynamic therapy on choroidal neovascular membranes. Arch Ophthalmol, June 1, 2006; 124(6): 815 - 823. [Abstract] [Full Text] [PDF] |
||||
![]() |
C-M Lai, S A Dunlop, L A May, M Gorbatov, M Brankov, W-Y Shen, N Binz, Y K. Lai, C E Graham, C J Barry, et al. Generation of transgenic mice with mild and severe retinal neovascularisation Br. J. Ophthalmol., July 1, 2005; 89(7): 911 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
G B Arden, R L Sidman, W Arap, and R O Schlingemann Spare the rod and spoil the eye Br. J. Ophthalmol., June 1, 2005; 89(6): 764 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Bhisitkul, G. S. Robinson, R. S. Moulton, K. P. Claffey, E. S. Gragoudas, and J. W. Miller An Antisense Oligodeoxynucleotide Against Vascular Endothelial Growth Factor in a Nonhuman Primate Model of Iris Neovascularization Arch Ophthalmol, February 1, 2005; 123(2): 214 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.H. V. Chong, J. Keonin, P. J. Luthert, C. I. Frennesson, D. M. Weingeist, R. L. Wolf, R. F. Mullins, and G. S. Hageman Decreased Thickness and Integrity of the Macular Elastic Layer of Bruch's Membrane Correspond to the Distribution of Lesions Associated with Age-Related Macular Degeneration Am. J. Pathol., January 1, 2005; 166(1): 241 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Slomiany and S. A. Rosenzweig Autocrine effects of IGF-I-induced VEGF and IGFBP-3 secretion in retinal pigment epithelial cell line ARPE-19 Am J Physiol Cell Physiol, September 1, 2004; 287(3): C746 - C753. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Slomiany and S. A. Rosenzweig IGF-1-Induced VEGF and IGFBP-3 Secretion Correlates with Increased HIF-1{alpha} Expression and Activity in Retinal Pigment Epithelial Cell Line D407 Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2838 - 2847. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Zarbin Current Concepts in the Pathogenesis of Age-Related Macular Degeneration Arch Ophthalmol, April 1, 2004; 122(4): 598 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-Y. Shen, S. Y. Lee, I. Yeo, C.-M. Lai, R. Mathur, D. Tan, I. J. Constable, and P. E. Rakoczy Predilection of the Macular Region to High Incidence of Choroidal Neovascularization After Intense Laser Photocoagulation in the Monkey Arch Ophthalmol, March 1, 2004; 122(3): 353 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sakurai, A. Anand, B. K. Ambati, N. van Rooijen, and J. Ambati Macrophage Depletion Inhibits Experimental Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3578 - 3585. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Rakic, V. Lambert, L. Devy, A. Luttun, P. Carmeliet, C. Claes, L. Nguyen, J.-M. Foidart, A. Noel, and C. Munaut Placental Growth Factor, a Member of the VEGF Family, Contributes to the Development of Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3186 - 3193. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sakurai, H. Taguchi, A. Anand, B. K. Ambati, E. S. Gragoudas, J. W. Miller, A. P. Adamis, and J. Ambati Targeted Disruption of the CD18 or ICAM-1 Gene Inhibits Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2743 - 2749. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Rakoczy, M. Brankov, A. Fonceca, T. Zaknich, B. C. Rae, and C.-M. Lai Enhanced Recombinant Adeno-Associated Virus-Mediated Vascular Endothelial Growth Factor Expression in the Adult Mouse Retina: A Potential Model for Diabetic Retinopathy Diabetes, March 1, 2003; 52(3): 857 - 863. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Wang, K. G. Rendahl, W. C. Manning, D. Quiroz, M. Coyne, and S. S. Miller AAV-Mediated Expression of Vascular Endothelial Growth Factor Induces Choroidal Neovascularization in Rat Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 781 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takahashi, Y. Saishin, Y. Saishin, K. Mori, A. Ando, S. Yamamoto, Y. Oshima, H. Nambu, M. B. Melia, D. P. Bingaman, et al. Topical Nepafenac Inhibits Ocular Neovascularization Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 409 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kreppel, T. T. Luther, I. Semkova, U. Schraermeyer, and S. Kochanek Long-Term Transgene Expression in the RPE after Gene Transfer with a High-Capacity Adenoviral Vector Invest. Ophthalmol. Vis. Sci., June 1, 2002; 43(6): 1965 - 1970. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hangai, T. Murata, N. Miyawaki, C. Spee, J. I. Lim, S. He, D. R. Hinton, and S. J. Ryan Angiopoietin-1 Upregulation by Vascular Endothelial Growth Factor in Human Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., June 1, 2001; 42(7): 1617 - 1625. [Abstract] [Full Text] |
||||
![]() |
C. Schwesinger, C. Yee, R. M. Rohan, A. M. Joussen, A. Fernandez, T. N. Meyer, V. Poulaki, J. J. K. Ma, T. M. Redmond, S. Liu, et al. Intrachoroidal Neovascularization in Transgenic Mice Overexpressing Vascular Endothelial Growth Factor in the Retinal Pigment Epithelium Am. J. Pathol., March 1, 2001; 158(3): 1161 - 1172. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |